David Altarac

David Altarac is a seasoned biopharmaceutical executive with extensive experience in regulatory affairs and medical leadership. Currently serving as Chief Medical Officer at Innoviva Specialty Therapeutics, Inc., a role commenced in February 2024, Altarac has previously held positions as Chief Medical Officer and Strategic Advisor at Innoviva, as well as Chief Medical Officer at Entasis Therapeutics. Prior roles include Senior Vice President of Regulatory Affairs and compliance at Shire, where responsibilities encompassed oversight of global regulatory strategies, and Vice President at Merck, where Altarac led regulatory affairs for emerging markets and managed worldwide regulatory activities across multiple therapeutic areas. Altarac's educational background includes a Doctor of Medicine from New York Medical College, a Master of Public Administration from New York University, and a Bachelor of Arts in Chemistry from Binghamton University.